The observation that patients with diseases involving the lymphoreticular system may have a decreased resistance to infectious agents has stimulated numerous studies of the immunological responsiveness of such individuals. It has been shown, for example, that patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MINI) have a decreased capacity to produce circulating antibody (1) (2) (3) (4) (5) (6) (7) (8) (9) and frequently have a low serum gamma globulin concentration ( 10, 11) . The severity of these serologic abnormalities is correlated in general with increased susceptibility to bacterial infection (12) . On the other hand, the delayed-type hypersensitivity skin response to several commonly encountered antigens was found to be either normal or only slightly depressed in patients with CLL (12, 13) ; other studies, however, demonstrated an impairment of the development of contact sensitivity to 2,4-dinitro-1-chlorobenzene in patients with various lymphoid neoplasms (14, 15) .
The purpose of this study was to define more precisely the nature of the immunologic defects in patients with CLL and MM and, in particular, to test the capacity for both a primary immune response and a response to antigens presumed to have been encountered before disease. Accordingly, four parameters of immunologic responsiveness were studied: primary antibody formation to bacteriophage 4X 174, the secondary antibody response to diphtheria toxoid, the development of primary delayed-type hypersensitivity to 2,4-dinitro-1-fluorobenzene (DNFB), and delayedtype hypersensitivity to eight commonly encountered microbial antigens. The results presented here indicate that CLL usually has a different pattern of immunologic deficiency from that observed in MM, but that in each disease, the capacity for a primary hypersensitivity response may be severely depressed, although hypersensitivity reactions to antigens previously encountered may appear intact. Methods
Patients
Patients and control subjects were selected from the wards of the third and fourth medical divisions of Bellevue Hospital. The diagnosis of CLL, MM, or Waldenstrom's macroglobulinemia was established according to conventional clinical and laboratory criteria (16) . Approximately one-half of the control group consisted of subjects who were convalescing from acute infectious diseases but who were otherwise normal; the remainder had chronic diseases not associated with known immunological abnormalities. No patients of either group had been treated with immunosuppressive drugs before or during the study.
An-tigens
Bacteriophage OX 174 containing 1011 plaque-forming particles per ml was prepared and purified as previously described (17) . In this paper, the number of phage particles will refer only to the plaque formers. Two dilutions in saline, containing 108 and 1010, respectively, were sterilized by the addition of 2. (20) . Complement Saline isohemagglutinins were determined by serial saline dilution with a Takatsky microtitrator. A 2% suspension of group A and B cells in saline was freshly prepared for all titrations. The titers in the control group were 1: 4 to 1: 32 for both anti-A and anti-B agglutinins.
Serum studies
Total serum protein was assayed by the biuret method (21) and read spectrophotometrically. Normal values were between 6.0 and 7.5 g per 100 ml.
Paper electrophoresis (22) was performed with a Spinco-Durrum cell apparatus using barbital buffer, pH 8.6, and ionic strength 0.075, for 14 hours at 2.5 ma. The paper strips were stained with bromphenol blue and integrated by densitometer.
Immunoelectrophoresis was performed with a SpincoDurrum cell apparatus by the micromethod described by Scheidegger (23). A barbital buffer system with pH 8.2 and ionic strength 0.05 was used, and electrophoresis was run for 2 hours at 4 ma per slide. Horse antihuman serum 8 was allowed to diffuse from the trough with the slides kept in a humid container overnight.
Gamma globulin levels in the sera were estimated by multiplying the percentage of normal gamma globulin obtained by paper electrophoresis by the total protein determined by the biuret method. Gamma globulin was also determined by the zinc turbidity method of Kunkel (24) . Normal values for gamma globulin were 0.75 to 1.25 g per 100 ml and 4 to 8 zinc turbidity U.
Results
Control subjects. All subjects had total protein and gamma globulin serum levels in the normal range (6.5 to 7.5 g per 100 ml) and Isohemagglutinin and gamma globulin levels were lower than in the controls. These observations, as well as the lack of correlation between the isohemagglutinin titers and gamma globulin values, have been made by previous investigators (25) . By immunoelectrophoresis, the y1m arc (19 S y-globulin) was absent in all but one patient (M.G.). The 71A arc was also missing in seven of ten, and the 72 line was frequently shortened and appeared more symmetrical than usual. In several sera, 72 appeared as double parallel lines. 9 In contrast to normal individuals, patients with CLL (Table IV) either did not respond or produced only trace amounts of anti-OX antibody 2 9 In two cases, an abnormal protein was detected by immunoelectrophoresis, in one (C.W.) as a macroglobulin and in the other (W.L.) as a slowly migrating 'Y2 paraprotein. In both instances a moderate elevation of y-globulin was detected by the zinc turbidity method. Indeed, because of a customary hypogammaglobulinemia in patients with CLL, the elevated zinc turbidity values suggested the possibility of concomitant paraproteinemia. (27) , and eight had Y2 type paraprotein. No difference was detected among the immunologic responses of these three groups of patients. In general, the serum studies resembled those ob- served in patients with CLL, i.e., isohemagglutinin all 12 patients, but six failed to develop detectable titers and gamma globulin levels were reduced sensitization to DNFB. (Table VI) . Macroglobulinemia of Waldenstriim. One paAs can be seen in Table VII , the anti-+6X re-tient with this disease demonstrated a secondary sponse was reduced but detectable in nine of 11, response to diphtheria toxoid (increase from 0.2 normal in one (J.B.), and not detectable in an-to 5 U) but was unable to produce detectable other. A rise in antitoxin titer occurred in all antibody against OX 174 despite three separate 14 patients; 11 of the postimmunization titers attempts at immunization (Table VII) . A secwere within the range observed in normals (>-0.5 ond injection of diphtheria toxoid resulted in a U). Delayed hypersensitivity to at least one further increase in antitoxin titer to 10 U. He commonly encountered antigen was observed in also did not develop delayed type hypersensitivity to DNFB, but responded to four of the eight skin testing antigens. Discussion These studies confirm previous results of others (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) that both CLL and MM are usually associated with an immunological deficiency disorder. The studies indicate, however, that CLL usually is associated with a different pattern of immunologic deficiency than that observed in MM. In ten patients with CLL, several of whom were asymptomatic and with only minimal organ enlargement, there was profound depression of serum y-globulin levels, primary immune response (antibody or delayed hypersensitivity), and the secondary antibody response. Only the expression of delayed-type skin reactivity to commonly encountered antigens was still consistently demonstrable. The severe impairment of antibody synthesis is well illustrated in two patients who showed marked delayed-type hypersensitivity to mumps antigen (one had a delayed-type skin reaction measuring 40 x 60 mm, the largest observed to mumps antigen in this study). These two patients, unlike control individuals with similar skin reactivity to mumps antigen, showed no rise in specific antibody levels after immunization with formalinized mumps vaccine. In contrast to these results, in the MM group which included several moribund patients, 11 of 14 showed a secondary antibody response, and 9 of 11, the capacity to give a detectable primary response (either antibody formation or delayed-type hypersensitivity). All these patients were capable of expressing delayed-type hypersensitivity to at least one of the commonly encountered antigens.
The observed difference in the deficiency patterns associated with these two diseases may simply represent a quantitative difference of qualitatively similar defects in the immune mechanism in which immunologic functions are lost in the following order: primary immune responsiveness, secondary antibody responsiveness, and delayed hypersensitivity reactivity to previously encountered antigens. These two deficiency disorders, however, appear to be qualitatively different from those disorders described in association with Hodgkin's disease and sarcoidosis. In the latter diseases, expression of delayed-type hypersensitivity is severely suppressed or absent, but antibody formation may appear normal (28) (29) (30) (31) . It is apparent, therefore, that different patterns of immunologic reactivity can be associated with different pathological entities involving the lymphoreticular system.
The present studies also indicate that the capacity for a primary response (antibody or delayed-type hypersensitivity) may be severely depressed, although expression of an already developed response (delayed-type skin reactivity to commonly encountered antigens or capacity for an anamnestic antibody response') may appear intact. Evidence for this dissociation of responsiveness is as follows: a) Fifteen patients with CLL or MIM did not develop a primary delayed type hypersensitivity response, but had skin reactions to commonly encountered antigens; no patients in these studies demonstrated the converse. b) A similar but less striking trend is seen in the pattern of the primary and secondary antibody responses of MM patients. c) Two patients, one with 71A myeloma (T.M.) and one with macroglobulinemia of Waldenstrdm had satisfactory secondary antitoxin responses (5 and 10 U of antitoxin, respectively), but neither patient produced detectable antibody to OX 174 despite three separately spaced injections of phage. The failure to detect primary, as opposed to secondary, antibody formation in these studies is not due to differences in sensitivity of the corresponding tests. The neutralization assays for OX and for antitoxin can each detect approximately 10-3 /Ag per ml of neutralizing antibody protein. This dissociation between primary and secondary responsiveness appears operationally analogous to that observed in experimental animals after treatment with either certain doses of ionizing radiation (32) 
Summary
Four parameters of immunologic responsiveness were studied in ten patients with chronic lymphocytic leukemia (CLL) and 14 with multiple myeloma (MM): primary anti-OX formation, secondary antitoxin formation, primary delayed hypersensitivity to 2,4-dinitro-1-fluorobenzene, and delayed hypersensitivity to eight antigens presumed to have been encountered before disease. The results indicate that the immunologic deficiency disorder associated with CLL is usually different from that observed in association with MM. In the former, only delayed skin reactivity to commonly encountered antigens was consistently demonstrable. In contrast, in the MM group, 11 of 14 showed a secondary antitoxin response, and 9 of 11 the capacity to give a primary response to either OX or 2,4-dinitro-1-fluorobenzene. Two patients, one with 'Y1A myeloma and one with macroglobulinemia of \Valdenstrdm had normal secondary antitoxin responses but were unable to produce a detectable primary anti-OX response.
